Historical salary details - Mr. Richard J. Berman, Chairman of the Board, Context Therapeutics Inc
Mr. Richard J. Berman is the Chairman of the Board of Context Therapeutics Inc.
Mr. Richard J. Berman
Chairman of the Board
-
Gross Remuneration
-
Current Company
Context Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Context Therapeutics Inc | Chairman of the Board | - | - |
| 2024 | CryoPort Inc | Lead Independent Director | 440.0 K | - |
| 2024 | BioVie Inc | Independent Director | 156.0 K | -41.5 % |
| 2024 | Context Therapeutics Inc | Chairman of the Board | 149.1 K | - |
| 2024 | Sidus Space Inc - Ordinary Shares - Class A | Director | 120 K | - |
| 2024 | Celularity Inc - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | BioVie Inc | Independent Director | 266.7 K | -36.8 % |
| 2023 | Celularity Inc - Ordinary Shares - Class A | Independent Director | - | - |
| 2023 | Sidus Space Inc - Ordinary Shares - Class A | Director | - | - |
| 2022 | CryoPort Inc | Lead Independent Director | 440.0 K | 3.7 % |
| 2022 | BioVie Inc | Independent Director | 421.7 K | -70.6 % |
| 2022 | Context Therapeutics Inc | Chairman of the Board | 149.2 K | -11.7 % |
| 2022 | COMSovereign Holding Corp. - 9.25% PRF PERPETUAL USD 25 - Ser A | Lead Independent Director | 75 K | -84.7 % |
| 2022 | Frontier Investment Corp - Ordinary Shares - Class A | Independent Director | - | - |
| 2021 | BioVie Inc | Independent Director | 1.4 M | - |
| 2021 | COMSovereign Holding Corp. - 9.25% PRF PERPETUAL USD 25 - Ser A | - | 489.7 K | - |
| 2021 | CryoPort Inc | Lead Independent Director | 424.5 K | -7.9 % |
| 2021 | Cuentas Inc | Independent Director | 236.9 K | - |
| 2021 | Context Therapeutics Inc | Chairman of the Board | 168.9 K | - |
| 2021 | Frontier Investment Corp - Ordinary Shares - Class A | Independent Director | - | - |
| 2021 | COMSovereign Holding Corp. | Lead Independent Director | - | - |
| 2020 | CryoPort Inc | Lead Independent Director | 461.1 K | 12.1 % |
| 2020 | COMSovereign Holding Corp. | Lead Independent Director | 127.0 K | - |
| 2020 | Immuron Limited - ADR | - | 30 K | -90.0 % |
| 2020 | Context Therapeutics Inc | Chairman of the Board | - | - |
| 2020 | Frontier Investment Corp - Ordinary Shares - Class A | Independent Director | - | - |
| 2020 | Cuentas Inc | Independent Director | - | - |
| 2019 | CryoPort Inc | Lead Independent Director | 411.4 K | 24.1 % |
| 2019 | Immuron Limited - ADR | Director | 300.5 K | - |
| 2019 | Ontrak Inc | Independent Director | 33.9 K | -66.9 % |
| 2019 | Lisata Therapeutics Inc | Independent Director | - | - |
| 2019 | COMSovereign Holding Corp. | Independent Director | - | - |
| 2019 | BioVie Inc | Independent Director | - | - |
| 2018 | CryoPort Inc | Lead Independent Director | 331.5 K | 48.5 % |
| 2018 | Ontrak Inc | Independent Director | 102.5 K | 210.3 % |
| 2018 | Immuron Limited - ADR | Director | - | - |
| 2017 | CryoPort Inc | Lead Independent Director | 223.2 K | 199.2 % |
| 2017 | Ontrak Inc | Independent Director | 33.0 K | - |
| 2016 | CryoPort Inc | Lead Independent Director | 74.6 K | -11.6 % |
| 2016 | Lisata Therapeutics Inc | Independent Director | - | - |
| 2015 | Lisata Therapeutics Inc | Independent Director | 169.0 K | -6.0 % |
| 2015 | CryoPort Inc | Director | 84.4 K | - |
| 2014 | Lisata Therapeutics Inc | Independent Director | 179.9 K | 26.5 % |
| 2013 | Lisata Therapeutics Inc | Independent Director | 142.2 K | 20.1 % |
| 2012 | Lisata Therapeutics Inc | Independent Director | 118.4 K | 97.3 % |
| 2011 | Lisata Therapeutics Inc | Independent Director | 60 K | - |
| 2010 | Seelos Therapeutics Inc | - | 18.5 K | -85.4 % |
| 2010 | Lisata Therapeutics Inc | Director | - | - |
| 2010 | Seelos Therapeutics Inc | Director | - | - |
| 2009 | Lisata Therapeutics Inc | Director | 749.6 K | 196.4 % |
| 2009 | Seelos Therapeutics Inc | Director | 126.8 K | 2.6 % |
| 2008 | Lisata Therapeutics Inc | Director | 252.9 K | -25.8 % |
| 2008 | Seelos Therapeutics Inc | Chairman of the Board | 123.5 K | 586.3 % |
| 2007 | Lisata Therapeutics Inc | Director | 340.8 K | 265.2 % |
| 2007 | Seelos Therapeutics Inc | Chairman of the Board of Directors | 18 K | - |
| 2006 | Lisata Therapeutics Inc | Director | 93.3 K | - |
| 2006 | Seelos Therapeutics Inc | President and Non-Executive Chairman | - | - |
| 2005 | Seelos Therapeutics Inc | Director, President and Chief Executive Officer | - | - |
| 2005 | Lisata Therapeutics Inc | Director | - | - |
| 2004 | Seelos Therapeutics Inc | Director | - | - |
| 2003 | Seelos Therapeutics Inc | Director | - | - |
| 2002 | Seelos Therapeutics Inc | Director | - | - |